Acumen PharmaceuticalsABOS
13F holders, Q1 2024 (March 31)80holders
2famous investors
$4.05avg. 13F price*
At the end of Q1 2024, 80 institutions reported holding Acumen Pharmaceuticals Inc. (ABOS) in their 13F filings. The largest holders were Ra Capital Management, L.P. ($60.5M), Sands Capital Alternatives, LLC ($13.8M) and Franklin Resources Inc. ($13.8M). 2 famous investors held it, including Israel Englander (0.0% of Millennium Management's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Acumen Pharmaceuticals Inc.
- CUSIP
- 00509G209
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 24 | $17.5M |
| Exits | 11 | $1.6M |
Ownership 80 holders
| Ra Capital Management, L.P. | 0.77% | No change | 14,932,063 | $60.5M |
| Sands Capital Alternatives, LLC | 3.34% | No change | 3,417,075 | $13.8M |
| Franklin Resources Inc. | 0.00% | Add +1.1% | 3,395,418 | $13.8M |
| Millennium Management | 0.01% | Add +75.9% | 2,629,541 | $10.6M |
| Rock Springs Capital Management LP | 0.24% | No change | 2,300,059 | $9.3M |
| FMR LLC | 0.00% | New | 2,089,000 | $8.5M |
| Laurion Capital Management LP | 0.21% | No change | 1,895,023 | $7.7M |
| Vanguard Group Inc. | 0.00% | Reduce -9.5% | 1,665,058 | $6.7M |
| Knollwood Investment Advisory, LLC | 1.19% | No change | 1,628,510 | $6.6M |
| T. Rowe Price Associates Inc. | 0.00% | New | 1,098,276 | $4.4M |
| Alyeska Investment Group, L.P. | 0.02% | Add +28.1% | 939,603 | $3.8M |
| Jane Street Group, LLC | 0.00% | Reduce -0.7% | 600,255 | $2.4M |
| Parkman Healthcare Partners LLC | 0.29% | Reduce -4.5% | 576,657 | $2.3M |
| Hudson Bay Capital Management LP | 0.02% | Reduce -0.8% | 560,000 | $2.3M |
| Pathstone Holdings, LLC | 0.01% | Add +0.2% | 480,181 | $1.9M |
| Schonfeld Strategic Advisors LLC | 0.01% | Reduce -18.4% | 458,484 | $1.9M |
| Goldman Sachs Group Inc. | 0.00% | Add +177.1% | 317,904 | $1.3M |
| Geode Capital Management, LLC | 0.00% | Add +7.8% | 285,139 | $1.2M |
| Ikarian Capital, LLC | 0.29% | Reduce -15.5% | 266,435 | $1.1M |
| Susquehanna International Group, LLP | 0.00% | Reduce -46.8% | 265,843 | $1.1M |
| Tang Capital Management LLC | 0.10% | No change | 246,895 | $1000K |
| Two Sigma Advisers, LP | 0.00% | Add +67.3% | 217,000 | $879K |
| BlackRock Inc. | 0.00% | Reduce -23.5% | 189,697 | $768K |
| Man Group plc | 0.00% | Add +29.7% | 187,585 | $760K |
| Two Sigma Investments, LP | 0.00% | Reduce -27.2% | 177,901 | $720K |
| Qube Research & Technologies Ltd | 0.00% | Add +89.1% | 167,588 | $679K |
| TD Asset Management Inc | 0.00% | New | 148,800 | $603K |
| Bridgeway Capital Management, LLC | 0.01% | New | 148,400 | $601K |
| Citigroup Inc. | 0.00% | Reduce -8.4% | 135,394 | $548K |
| Squarepoint Ops LLC | 0.00% | Add +114.3% | 113,232 | $459K |
| Wellington Management Group LLP | 0.00% | New | 112,258 | $455K |
| HRT Financial LP | 0.00% | New | 105,117 | $425K |
| New York Life Investment Management LLC | 0.00% | New | 95,089 | $385K |
| Marshall Wace, LLP | 0.00% | New | 89,707 | $363K |
| State Street Corp. | 0.00% | Reduce -3.9% | 81,778 | $331K |
| Bank of America Corp. | 0.00% | Reduce -22.8% | 80,616 | $326K |
| Catalyst Financial Partners LLC | 0.08% | No change | 89,699 | $311K |
| JPMorgan Chase & Co. | 0.00% | Add +111.8% | 71,890 | $291K |
| Balyasny Asset Management L.P. | 0.00% | Add +210.8% | 63,949 | $259K |
| Susquehanna Fundamental Investments, LLC | 0.01% | New | 62,518 | $253K |
| Dimensional Fund Advisors LP | 0.00% | Add +10.6% | 61,728 | $250K |
| Manufacturers Life Insurance Company, The | 0.00% | New | 60,041 | $243K |
| Marathon Trading Investment Management LLC | 0.10% | New | 60,000 | $243K |
| Northern Trust Corp. | 0.00% | Add +0.2% | 56,773 | $230K |
| Brevan Howard Capital Management LP | 0.02% | New | 56,369 | $228K |
| Boothbay Fund Management, LLC | 0.01% | Reduce -37.1% | 51,708 | $209K |
| Morgan Stanley | 0.00% | Add +110.6% | 48,712 | $197K |
| Barclays PLC | 0.00% | Reduce -0.1% | 47,310 | $192K |
| Y-Intercept (Hong Kong) Ltd | 0.01% | Add +92.2% | 37,191 | $151K |
| Prelude Capital Management, LLC | 0.01% | Add +27.1% | 37,000 | $150K |
| American Century Companies Inc. | 0.00% | Add +39.9% | 34,604 | $140K |
| Bank of Montreal | 0.00% | New | 31,900 | $132K |
| Intrepid Financial Planning Group LLC | 0.05% | No change | 30,150 | $122K |
| Group One Trading LLC | 0.00% | Add +271.7% | 28,037 | $114K |
| Point72 Asia (Singapore) Pte. Ltd. | 0.03% | Add +1277.8% | 27,556 | $112K |
| ExodusPoint Capital Management, LP | 0.00% | Reduce -20.6% | 25,620 | $104K |
| Gsa Capital Partners LLP | 0.01% | New | 25,370 | $103K |
| Jump Financial, LLC | 0.00% | Reduce -76.8% | 23,951 | $97K |
| OMERS ADMINISTRATION Corp | 0.00% | New | 23,800 | $96K |
| Citadel Advisors | 0.00% | Reduce -82.2% | 23,351 | $95K |
| Susquehanna Portfolio Strategies, LLC | 0.00% | No change | 21,903 | $89K |
| Jefferies Financial Group Inc. | 0.00% | New | 19,000 | $77K |
| Pinnacle Wealth Management Advisory Group, LLC | 0.01% | New | 18,020 | $73K |
| Pinnacle Associates Ltd. | 0.00% | New | 18,020 | $73K |
| Stifel Financial Corp. | 0.00% | Reduce -9.3% | 14,650 | $59K |
| SG Americas Securities, LLC | 0.00% | New | 12,856 | $52K |
| Algert Global LLC | 0.00% | New | 12,410 | $50K |
| LMR Partners LLP | 0.00% | New | 11,503 | $47K |
| CTC Alternative Strategies, Ltd. | 0.03% | New | 11,100 | $45K |
| Chicago Partners Investment Group LLC | 0.00% | Reduce -23.8% | 13,958 | $44K |
| Osaic Holdings, Inc. | 0.00% | Add +2500.0% | 10,400 | $42K |
| Integrated Wealth Concepts LLC | 0.00% | Reduce -30.8% | 10,100 | $41K |
| UBS Group AG | 0.00% | Add +82937.5% | 6,643 | $27K |
| Cubist Systematic Strategies, LLC | 0.00% | Reduce -92.9% | 2,396 | $10K |
| Sandy Spring Bank | 0.00% | New | 1,500 | $6K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -95.2% | 1,410 | $6K |
| Wells Fargo & Company | 0.00% | Reduce -45.2% | 1,208 | $5K |
| Kelly Financial Services LLC | 0.00% | No change | 944 | $4K |
| Macquarie Group Ltd. | 0.00% | New | 1,247 | $5 |
| Royal Bank of Canada | 0.00% | Reduce -84.7% | 102 | $0 |
"% of holder's portfolio" is ABOS's weight in each manager's 13F, not the share of Acumen Pharmaceuticals Inc. the manager owns.